Understanding therapeutic targets in thrombotic thrombocytopenic purpura
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Intensive care medicine - 43(2017), 9 vom: 01. Sept., Seite 1398-1400 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Joly, Bérangère S [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 17.08.2018 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00134-016-4662-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM268277710 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM268277710 | ||
| 003 | DE-627 | ||
| 005 | 20231224222345.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-016-4662-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0894.xml |
| 035 | |a (DE-627)NLM268277710 | ||
| 035 | |a (NLM)28116452 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Joly, Bérangère S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Understanding therapeutic targets in thrombotic thrombocytopenic purpura |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.08.2018 | ||
| 500 | |a Date Revised 13.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ADAMTS13 Deficiency | |
| 650 | 4 | |a Eculizumab | |
| 650 | 4 | |a High Molecular Weight Multimers | |
| 650 | 4 | |a Thrombotic Thrombocytopenic Purpura | |
| 650 | 4 | |a Thrombotic Thrombocytopenic Purpura Patient | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Immunologic Factors |2 NLM | |
| 650 | 7 | |a ADAMTS13 Protein |2 NLM | |
| 650 | 7 | |a EC 3.4.24.87 |2 NLM | |
| 700 | 1 | |a Vanhoorelbeke, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Veyradier, Agnès |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d 1993 |g 43(2017), 9 vom: 01. Sept., Seite 1398-1400 |w (DE-627)NLM000234818 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2017 |g number:9 |g day:01 |g month:09 |g pages:1398-1400 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00134-016-4662-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2017 |e 9 |b 01 |c 09 |h 1398-1400 | ||